Summary
To establish a specific and sensitive radioimmunoassay (RIA) for antiarrhythmic peptide (AAP) and study serum AAP levels in normal Sprague-Dawley rats (NR) and spontaneous hypertension rats (SHR), AAP-bovine serum albumin (BSA) conjugate was prepared by ammonium bicarbonate method. The New Zealand rabbits were immunized by administering intradermally the conjugate. Then the rabbit anti-AAP serum was produced and iodinated AAP was made by Bolton-Hunter method. The RIA for serum AAP was set up and serum AAP levels in NR and SHR were determined. The minimal detectable range of the AAP RIA was (0.45±0.06) μg/L. The affinity constant for antiserum was 1.05×109 L/mol, and the rate of cross-reactivity with atrial peptide (AP) and human growth hormone (hGH) were 0.12% and 0.20%, respectively. The mean recovery rate of high, medium and low doses was 97.6%, and the mean coefficients of variation for intra-and interbath-assay were (6.43±0.85)% and (9.62±1.04)%, respectively. The mean levels of AAP in NR with different age (3 months, 8–10 months and 18–20 months) were (1.75±0.13) μg/L, (1.74±0.11) μg/L and (1.79±0.15) μg/L, respectively, while those in SHR with different age (3 months, 8–10 months and 18–20 months) were (2.38±0.35) μg/L, (2.54±0.25) μg/L and (2.83±0.21) μg/L, respectively. The levels of serum AAP showed a positive correlation with blood pressure (r=0.8667,P<0.05). It was indicated that this AAP RIA had high specificity, high accuracy and good reproducibility. The levels of serum AAP had a close relation with blood pressure.
Similar content being viewed by others
References
Aonuma S, Kohama Y, Makino Tet al. Studies on heart. X XI. Inhibitory effect of an atrial peptide (AAP) on several drug-induced arrhythmias in vivo. Yakugaku Zasshi, 1983,103:662
Aonuma S, Kohama Y, Makino Tet al. Studies on heart. X X IV. Inhibitory effect of antiarrhythmic peptide (AAP) on experimental thromboses. Chem Pharm Bull, 1984, 32:219
Kohama Y, Iwabuchi K, Okabe Met al. Potent platelet antiaggregant action of an antiarrhythmic peptide (AAP). J Pharmacobiodyn, 1986,9:182
Kohama Y, Kawahara Y, Okabe Met al. Determination of immunoreactive antiarrythmic peptide (AAP) in rats. J Pharmacobiodyn, 1985,8:1024
Resnick L M. Celluar Ca2+ and Mg2+ metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. Am J Med. 1992:93 (suppl 2A):11S
Aonuma S, Kohama Y, Akai Ket al. Studies on heart. X IX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters. Chem Pharm Bull, 1980,28:3332
Aonuma S, Kohama Y, Makino Tet al. Studies on heart. X XI. Amino acid sequence of antiarrhythmic peptide (AAP) isolated from atria. J Pharmacobiodyn, 1982,5:40
Author information
Authors and Affiliations
Additional information
WU Zhijian, male, born in 1968, M. D., Ph.D.
Rights and permissions
About this article
Cite this article
Zhijian, W., Yongxue, Z. Radioimmunoassay of antiarrhythmic peptide and its application. Current Medical Science 23, 44–47 (2003). https://doi.org/10.1007/BF02829460
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02829460